CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 

Cumulative Frequency Therapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

FREQ's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

FREQ Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -44.28 % -42.27 % -36.49 % -32.04 % -26.29 %
Y / Y Total Liabilities Growth -1.87 % -0.68 % -18.46 % -24.5 % 58.57 %
Leverage Ratio for Trailing Twelve Months Period 0.51 0.44 0.39 0.37 0.36
Total Ranking # 1031 # 1080 # 959 # 1014 # 809
Seq. Equity Growth -14.48 % -14.93 % -13.88 % -11.07 % -11.4 %
Seq. Total Liabilities Growth 0.44 % 2.94 % -4.15 % -0.97 % 1.65 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 0.44%, Leverage Ratio for Trailing Twelve Months Period improved to 0.51, above Frequency Therapeutics Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 271 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Frequency Therapeutics Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 1031, from total ranking in previous quarter at 1080.

What is Leverage Ratio?
Who are FREQ's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 272
Sector # 507
S&P 500 # 1030


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.89 0.45 0.27
(Mar 31 2020)   (Sep 30 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Zogenix Inc   1.39 
Prestige Consumer Healthcare Inc   1.38 
Legend Biotech Corporation  1.37 
Evoke Pharma Inc   1.37 
Ani Pharmaceuticals inc  1.36 
Ocular Therapeutix Inc   1.36 
Spectrum Pharmaceuticals Inc   1.33 
Aytu Biopharma inc   1.33 
Pacira Biosciences inc   1.32 
Pfizer Inc  1.31 
Amryt Pharma Plc  1.29 
Catalent Inc   1.29 
Yumanity Therapeutics Inc   1.26 
Johnson and Johnson  1.24 
Zealand Pharma A  1.23 
Unity Biotechnology Inc.  1.21 
Royalty Pharma Plc  1.13 
Allarity Therapeutics Inc   1.13 
Harmony Biosciences Holdings inc   1.12 
Lifevantage Corp  1.11 
Cumberland Pharmaceuticals Inc   1.11 
Chembio Diagnostics Inc   1.10 
Promis Neurosciences Inc   1.09 
Verrica Pharmaceuticals Inc   1.09 
Ainos Inc   1.06 
Syros Pharmaceuticals Inc   1.06 
Pharming Group N v   1.06 
Biovie Inc   1.06 
Innoviva Inc   1.06 
Rvl Pharmaceuticals Plc  1.06 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BURL's Profile

Stock Price

BURL's Financials

Business Description

Fundamentals

Charts & Quotes

BURL's News

Suppliers

BURL's Competitors

Customers & Markets

Economic Indicators

BURL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071